Advanced search
Publication Cover
Journal of Medical Economics Volume 19, 2016 - Issue 10
Submit an article Journal homepage
783
Views
5
CrossRef citations to date
0
Altmetric
Cardiovascular

A novel cost-effectiveness model of prescription eicosapentaenoic acid extrapolated to secondary prevention of cardiovascular diseases in the United States

Sephy PhilipAmarin Pharma Inc., Bedminster, NJ, USA; Correspondence[email protected]
,
Sumita ChowdhuryConsultant to Amarin Pharma Inc., Bedminster, NJ, USA;
,
John R. NelsonCalifornia Cardiovascular Institute, Fresno, CA, USA;
,
P. Benjamin EverettAmarin Pharma Inc., Bedminster, NJ, USA;
,
Carolyn K. Hulme-LoweExponent, Alexandria, VA, USA
&
Jordana K. SchmierExponent, Alexandria, VA, USA
Pages 1003-1010 | Received 27 Apr 2016, Accepted 27 Jun 2016, Published online: 15 Jul 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jean Lachaine, Jean-Nicolas Charron, Jean C Gregoire, Robert A Hegele & Lawrence A Leiter. (2023) Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada. ClinicoEconomics and Outcomes Research 15, pages 295-308.
Read now
Kamini Trivedi, Viet Le & John R. Nelson. (2021) The case for adding eicosapentaenoic acid (icosapent ethyl) to the ABCs of cardiovascular disease prevention. Postgraduate Medicine 133:1, pages 28-41.
Read now

Articles from other publishers (3)

Rosalia Crupi & Salvatore Cuzzocrea. (2022) Role of EPA in Inflammation: Mechanisms, Effects, and Clinical Relevance. Biomolecules 12:2, pages 242.
Crossref
Cesare R Sirtori, Shizuya Yamashita, Maria Francesca Greco, Alberto Corsini, Gerald F Watts & Massimiliano Ruscica. (2019) Recent advances in synthetic pharmacotherapies for dyslipidaemias. European Journal of Preventive Cardiology 27:15, pages 1576-1596.
Crossref
Satoshi Kodera, Hiroyuki Morita, Arihiro Kiyosue, Jiro Ando & Issei Komuro. (2018) Cost-Effectiveness of Statin Plus Eicosapentaenoic Acid Combination Therapy for Cardiovascular Disease Prevention in Japanese Patients With Hypercholesterolemia　― An Analysis Based on the Japan Eicosapentaenoic Acid Lipid Intervention Study (JELIS) ―. Circulation Journal 82:4, pages 1076-1082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.